Greedy Insider
RYTM Insider Trades and Greediness Scores
RHYTHM PHARMACEUTICALS, INC. (RYTM) insider trades: since Dec 11, 2025, Greedy Insider recorded 0 open-market buys and 56 sales on Form 4 from 9 insiders. The strongest recent filing scored 92 (Strong).
Who bought and who sold
Across the last 56 scoreable Form 4 transactions in RYTM, 0 were open-market purchases and 56 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.
| Insider | Role | Type | Shares | Date | Score | ||
|---|---|---|---|---|---|---|---|
| Meeker David P | President | Sell | 6439.0 | 655145.06 | 2026-09-14 | 67 | View |
| Meeker David P | President | Sell | 30746.0 | 3146760.8 | 2026-09-14 | 78 | View |
| Meeker David P | President | Sell | 8698.0 | 899634.1 | 2026-09-14 | 69 | View |
| Meeker David P | President | Sell | 1817.0 | 189964.98 | 2026-09-14 | 63 | View |
| Meeker David P | President | Sell | 2300.0 | 241937.0 | 2026-09-14 | 63 | View |
| Smith Hunter C | CFO | Sell | 23072.0 | 2413033.5 | 2026-08-31 | 82 | View |
| Smith Hunter C | CFO | Sell | 28188.0 | 2993647.2 | 2026-08-31 | 82 | View |
| Smith Hunter C | CFO | Sell | 11514.0 | 1213232.5 | 2026-08-31 | 81 | View |
| Garfield Alastair | Chief Scientific Officer | Sell | 3400.0 | 402166.62 | 2026-08-13 | 82 | View |
| Garfield Alastair | Chief Scientific Officer | Sell | 2007.0 | 233031.36 | 2026-08-13 | 78 | View |
The strongest recent filing
Smith Hunter C (CFO) sold 10,750 shares of RHYTHM PHARMACEUTICALS, INC. on Feb 1, 2026, a filing that scored 92 (Strong). It scored Strong because a senior insider was trading and several insiders moved the same way within a week. The score describes the filing, not future returns. This is not investment advice.
Cluster activity
A cluster buy is present: 7 insiders (Smith Hunter C, Shulman Joseph, Meeker David P, Lee Jennifer Kayden) traded RYTM the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.
How this compares with RHYTHM PHARMACEUTICALS, INC.'s own history
Open-market buys make up 0% of the 56 scoreable RYTM transactions on record between Dec 11, 2025 and Sep 14, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.
Methodology and sources
Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.
Key facts
- Scoreable Form 4 transactions on record: 56
- Open-market buys: 0
- Sales: 56
- Distinct insiders: 9
- Strongest recent Greediness Score: 92 (Strong)
Primary sources
Related
- Strongest filing
- RYTM in the live feed
- How the Greediness Score works
- What is a cluster buy?
- Form 4 transaction codes
The score describes the filing, not future returns. This is not investment advice.